Literature DB >> 10602070

Fluorine ion-implanted polystyrene improves growth and viability of vascular smooth muscle cells in culture.

L Bacáková1, V Mares, M G Bottone, C Pellicciari, V Lisá, V Svorcík.   

Abstract

Vascular smooth muscle cells derived from the rat aorta were cultured on unmodified or F(+) ion-implanted polystyrene (5 x 10(12) or 5 x 10(14) ions/cm(2), energy 150 keV). In 1-day-old cultures, the cells adhered to the modified polystyrene in higher numbers and over larger contact areas. Increased resistance of the cells to trypsin-mediated detachment from the growth support indicated an improved adhesion of cells to the modified polymer at later culture intervals. The cells cultured on ion-modified polymers also were larger and had a higher total protein content. By use of immunocytochemistry, several specific protein species were increased, including the cytoskeletal alpha-actin and vimentin and the plasma membrane-associated vinculin, talin, alpha-v integrins, ICAM-1, and VCAM-1, which account for stronger cell-cell and cell-extracellular matrix adhesion. The lower number of cells found floating in the medium suggests that the spontaneous detachment of cells from the modified polystyrene was lower and that the viability of the adhered cell population was higher. As was shown by the two-parameter flow-cytometric measurements of BrdU incorporation and DNA content, as well as by (3)H-thymidine autoradiography, the cell proliferation on samples modified by the dose of 5 x 10(12) ions/cm(2) was similar to that in controls; and at the dose of 5 x 10(14) ions/cm(2), it tended to be even lower. The cells grown on the polymer implanted with the dose of 5 x 10(12) ions/cm(2) responded to a new artificially created cell-free area in a confluent cell layer by more intense migration whereas at the dose of 5 x 10(14) ions/cm(2), the migration ability of cells was similar to that on the unmodified polymer. The data revealed a higher biocompatibility of ion-implanted polystyrene with vascular smooth muscle cells in culture. There was better adhesion, differentiation, and survival, and there was neither excessive migration nor proliferation. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10602070     DOI: 10.1002/(sici)1097-4636(20000305)49:3<369::aid-jbm10>3.0.co;2-w

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  5 in total

1.  Dielectric study of the adhesion of mesenchymal stem cells from human umbilical cord on a sugarcane biopolymer.

Authors:  A S Fragoso; M B Silva; C P de Melo; J L A Aguiar; C G Rodrigues; P L de Medeiros; J F Branco Junior; C A S Andrade; M D L Oliveira
Journal:  J Mater Sci Mater Med       Date:  2013-09-27       Impact factor: 3.896

Review 2.  Surface Modification of Polymer Substrates for Biomedical Applications.

Authors:  Oldřich Neděla; Petr Slepička; Václav Švorčík
Journal:  Materials (Basel)       Date:  2017-09-21       Impact factor: 3.623

3.  Improved adhesion, growth and maturation of vascular smooth muscle cells on polyethylene grafted with bioactive molecules and carbon particles.

Authors:  Martin Parizek; Nikola Kasalkova; Lucie Bacakova; Petr Slepicka; Vera Lisa; Martina Blazkova; Vaclav Svorcik
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

4.  Adhesion, growth, and maturation of vascular smooth muscle cells on low-density polyethylene grafted with bioactive substances.

Authors:  Martin Parizek; Nikola Slepickova Kasalkova; Lucie Bacakova; Zdenek Svindrych; Petr Slepicka; Marketa Bacakova; Vera Lisa; Vaclav Svorcik
Journal:  Biomed Res Int       Date:  2013-03-24       Impact factor: 3.411

5.  Combining Biologically Active β-Lactams Integrin Agonists with Poly(l-lactic acid) Nanofibers: Enhancement of Human Mesenchymal Stem Cell Adhesion.

Authors:  Giulia Martelli; Nora Bloise; Andrea Merlettini; Giovanna Bruni; Livia Visai; Maria Letizia Focarete; Daria Giacomini
Journal:  Biomacromolecules       Date:  2020-02-14       Impact factor: 6.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.